Cargando…
Why has the incidence of tuberculosis not reduced in London during the COVID-19 pandemic?
Autores principales: | Lewer, Dan, Mulchandani, Ranya, Roche, Anita, Cosgrove, Catherine, Anderson, Charlotte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754446/ https://www.ncbi.nlm.nih.gov/pubmed/35032431 http://dx.doi.org/10.1016/S2213-2600(22)00012-1 |
Ejemplares similares
-
High COVID-19 death rates in prisons in England and Wales, and the need for early vaccination
por: Braithwaite, Isobel, et al.
Publicado: (2021) -
Are changes in the gut microbiome a contributor or consequence of autism—why not both?
por: Özcan, Ezgi, et al.
Publicado: (2022) -
Why the complications of COVID-19 patients differ in elderly and young cancer patients
por: Bravaccini, Sara, et al.
Publicado: (2022) -
Imaging latent tuberculosis infection with radiolabeled nitroimidazoles
por: Ankrah, Alfred O., et al.
Publicado: (2016) -
Supporting families with tuberculosis during COVID-19 in Khayelithsa, South Africa
por: Apolisi, Ivy, et al.
Publicado: (2022)